George J. Morrow, Director at NEUROCRINE BIOSCIENCES INC (NBIX), sold 60,000 shares at $139.41 ($8.4M) on 2024-03-14, disclosed to the SEC on 2024-03-15.
Scheduled sale ($8.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.41 | 20,000 | $2.8M | 33.3% |
| 2 | $139.42 | 20,000 | $2.8M | 33.3% |
| 3 | $139.42 | 20,000 | $2.8M | 33.3% |
| Total | $139.42 avg | 60,000 | $8.4M | 100% |
| Filing → |
| ALGN | SELL | 2021-02-08 | $18.7M | — | Filing → |
| ALGN | SELL | 2020-11-04 | $2.4M | — | Filing → |
| ALGN | SELL | 2020-10-28 | $18.6M | — | Filing → |